McMaster University
Investigating microbial proteolytic activity in intestinal inflammation
Abstract
dc:description.abstractProteases within the intestinal lumen, derived from the host and resident microbiota, regulate gastrointestinal physiology. However, excessive proteolytic activity has been implicated in intestinal inflammation, including ulcerative colitis (UC) and Crohn’s disease (CD). Although increased microbial proteolytic activity has been implicated in UC pathogenesis, its contribution to CD, the factors driving pro-inflammatory activity, and anti-protease therapeutic potential remained unclear. In Chapter 3, I investigated CD-associated microbial proteolytic activity using germ-free mice colonized with low or high proteolytic CD microbiota (LPA or HPA). 16S rRNA gene sequencing showed higher predicted Hungatella hathewayi proteases in CD-HPA versus CD-LPA mice. CD-HPA microbiota drives colitogenic activity through protease-activated receptor-2 cleavage. Altogether this supports a role for microbial proteases in CD pathogenesis. In Chapter 4, I investigated clinical associations of HPA using a pan-Canadian longitudinal IBD cohort. Approximately one-third of IBD patients had HPA, remaining stable over one year and predominantly attributed to serine proteases. HPA associated with bowel symptoms in CD, but not in UC. Future metagenomic analysis will help define taxonomic and functional characteristics associated with HPA in this patient cohort. Altogether, this work will help identify the subset of patients that may benefit from anti-proteolytic therapy. In Chapter 5, I investigated dietary drivers of HPA using gnotobiotic mouse models. A high-salt diet (HSD) induced HPA in a subset of UC donor microbiota, particularly those enriched in predicted proteolytic taxa, and worsened disease activity. Established HPA was attenuated by delivery of anti-protease elafin by probiotic Lacticaseibacillus rhamnosus. Altogether, this thesis identifies microbial proteolytic activity as a modifiable contributor to intestinal inflammation and bowel symptoms in a subset of patients with IBD. Dietary salt can induce HPA in susceptible microbiota, while probiotic anti-protease therapy can attenuate HPA-associated inflammation, supporting stratification by luminal proteolytic activity to identify patients that may likely benefit from anti-protease therapy.
Degree
thesis:*- Department dc:contributor.department
- Health Sciences
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hann, Amber
- Advisor dc:contributor.advisor
-
- Verdu, Elena
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivs 2.5 Canada
- Licence dc:rights.uri
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.71548/2310